2025
1145 Higher Proceduralist Stroke Thrombectomy Volume is Associated With Reduced Inpatient Mortality
Koo A, Renedo D, Ney J, Amllay A, Kanzler M, Stogniy S, Alawieh A, Sujijantarat N, Antonios J, Al Kasab S, Malhotra A, Hebert R, Matouk C, de Havenon A. 1145 Higher Proceduralist Stroke Thrombectomy Volume is Associated With Reduced Inpatient Mortality. Neurosurgery 2025, 71: 177-178. DOI: 10.1227/neu.0000000000003360_1145.Peer-Reviewed Original ResearchCut-pointsAbsolute risk of deathAssociated with lower oddsState Inpatient DatabasesFlorida State Inpatient DatabaseIn-hospital moralityRates of in-hospital mortalityPrimary study outcomeCare certificationRisk of deathOptimal cut-pointAssociated with reduced inpatient mortalityThrombectomy-capable stroke centersOverall careRetrospective cohort studyAIS patientsIn-Hospital DeathLow-volume cohortLower oddsIn-Hospital MortalityPotential confoundersAbsolute riskVolume cohortsInpatient mortalityCohort study
2024
Risks of grade reclassification among patients with Gleason grade group 1 prostate cancer and PI-RADS 5 findings on prostate MRI
Sundaresan V, Webb L, Rabil M, Golos A, Sutherland R, Bailey J, Rajwa P, Seibert T, Loeb S, Cooperberg M, Catalona W, Sprenkle P, Kim I, Leapman M. Risks of grade reclassification among patients with Gleason grade group 1 prostate cancer and PI-RADS 5 findings on prostate MRI. Urologic Oncology Seminars And Original Investigations 2024, 43: 193.e19-193.e26. PMID: 39706698, DOI: 10.1016/j.urolonc.2024.11.007.Peer-Reviewed Original ResearchConceptsPI-RADS 5 lesionsGG1 prostate cancerPI-RADSGG1 diseaseFusion biopsyRadical prostatectomyGleason gradeProstate cancerActive surveillanceGrade Group 1 prostate cancerSingle-institution retrospective analysisOptimal management of patientsMRI-ultrasound fusion biopsyLong-term outcome dataProstate Imaging ReportingMultivariate modelGenomic classifier scoresManagement of patientsPrimary study outcomeAssociated with upgradingMulti-institutional dataGleason upgradingTumor upgradingSurveillance biopsiesProstate MRIHigher proceduralist stroke thrombectomy volume is associated with reduced inpatient mortality
Koo A, Renedo D, Ney J, Amllay A, Kanzler M, Stogniy S, Alawieh A, Sujijantarat N, Antonios J, Al Kasab S, Malhotra A, Hebert R, Matouk C, de Havenon A. Higher proceduralist stroke thrombectomy volume is associated with reduced inpatient mortality. Journal Of NeuroInterventional Surgery 2024, jnis-2024-022021. PMID: 39214687, DOI: 10.1136/jnis-2024-022021.Peer-Reviewed Original ResearchIn-Hospital DeathIn-Hospital MortalityAcute ischemic strokeCut-pointsAbsolute risk of deathAssociated with lower oddsState Inpatient DatabasesFlorida State Inpatient DatabaseIn-hospital moralityRates of in-hospital mortalityDiagnosis of acute ischemic strokePrimary study outcomeRisk of deathStroke careOptimal cut-pointAssociated with reduced inpatient mortalityEndovascular thrombectomyRetrospective cohort studyLower oddsPotential confoundersAbsolute riskAcute ischemic stroke patientsInpatient mortalityCohort studyInpatient DatabaseAssociations Between Prostate Magnetic Resonance Imaging, Genomic Testing, and Treatment for Localized Prostate Cancer
Sundaresan V, Wang R, Long J, Sprenkle P, Seibert T, Loeb S, Cooperberg M, Catalona W, Ma X, Gross C, Leapman M. Associations Between Prostate Magnetic Resonance Imaging, Genomic Testing, and Treatment for Localized Prostate Cancer. Urology Practice 2024, 11: 965-973. PMID: 39196719, DOI: 10.1097/upj.0000000000000679.Peer-Reviewed Original ResearchLocalized prostate cancerClinically localized prostate cancerHigh-risk diseaseProstate MRIProstate cancerTreatment intensificationIntensified treatmentGenomic testingTreated patientsProstate magnetic resonance imagingEnd Results databaseLong-term patient outcomesProstate cancer prognosisRetrospective cohort studyAssociated with decreased oddsRisk stratification toolPrimary study outcomeAssociated with increased oddsMagnetic resonance imagingResults databaseStratification toolTreatment patientsCohort studyRisk strataCancer prognosisImpact of sleep quality and physical activity on blood pressure variability
de Havenon A, Falcone G, Rivier C, Littig L, Petersen N, de Villele P, Prabhakaran S, Kimberly W, Mistry E, Sheth K. Impact of sleep quality and physical activity on blood pressure variability. PLOS ONE 2024, 19: e0301631. PMID: 38625967, PMCID: PMC11020843, DOI: 10.1371/journal.pone.0301631.Peer-Reviewed Original ResearchConceptsSleep qualityPhysical activityOdds ratioCohort of community-dwelling adultsCommunity-dwelling adultsExcess relative riskBlood pressure variabilityExamined sleep qualityPoor sleep qualitySystolic blood pressure standard deviationSleep interruptionBody mass indexPhysical inactivityPrimary study outcomeStep countsImpact of sleep qualityLowest tertileRelative riskHigh blood pressure variabilityHome measurement devicesActivity levelsExposure statusPoor sleepMass indexStudy outcomesRISKS OF GRADE RECLASSIFICATION AMONG PATIENTS WITH GLEASON GRADE GROUP 1 PROSTATE CANCER AND PI-RADS 5 FINDINGS ON PROSTATE MRI
Sundaresan V, Webb L, Rabil M, Golos A, Sutherland R, Sprenkle P, Kim I, Leapman M. RISKS OF GRADE RECLASSIFICATION AMONG PATIENTS WITH GLEASON GRADE GROUP 1 PROSTATE CANCER AND PI-RADS 5 FINDINGS ON PROSTATE MRI. Urologic Oncology Seminars And Original Investigations 2024, 42: s79. DOI: 10.1016/j.urolonc.2024.01.222.Peer-Reviewed Original ResearchGleason Grade Group 1PI-RADS 5 lesionsPI-RADSProstate biopsyProstate cancerGleason upgradingRadical prostatectomyActive surveillanceProstate MRIMultivariate logistic regressionGrade Group 1 prostate cancerConversion to active treatmentOptimal management of patientsGrade group 1PI-RADS 5Gleason grade groupProstate Imaging ReportingDied of diseaseManagement of patientsLogistic regressionPrimary study outcomeAssociated with oddsMedian PSAMetastatic diseaseGrade disease
2023
Researching COVID to Enhance Recovery (RECOVER) adult study protocol: Rationale, objectives, and design
Horwitz L, Thaweethai T, Brosnahan S, Cicek M, Fitzgerald M, Goldman J, Hess R, Hodder S, Jacoby V, Jordan M, Krishnan J, Laiyemo A, Metz T, Nichols L, Patzer R, Sekar A, Singer N, Stiles L, Taylor B, Ahmed S, Algren H, Anglin K, Aponte-Soto L, Ashktorab H, Bassett I, Bedi B, Bhadelia N, Bime C, Bind M, Black L, Blomkalns A, Brim H, Castro M, Chan J, Charney A, Chen B, Chen L, Chen P, Chestek D, Chibnik L, Chow D, Chu H, Clifton R, Collins S, Costantine M, Cribbs S, Deeks S, Dickinson J, Donohue S, Durstenfeld M, Emery I, Erlandson K, Facelli J, Farah-Abraham R, Finn A, Fischer M, Flaherman V, Fleurimont J, Fonseca V, Gallagher E, Gander J, Gennaro M, Gibson K, Go M, Goodman S, Granger J, Greenway F, Hafner J, Han J, Harkins M, Hauser K, Heath J, Hernandez C, Ho O, Hoffman M, Hoover S, Horowitz C, Hsu H, Hsue P, Hughes B, Jagannathan P, James J, John J, Jolley S, Judd S, Juskowich J, Kanjilal D, Karlson E, Katz S, Kelly J, Kelly S, Kim A, Kirwan J, Knox K, Kumar A, Lamendola-Essel M, Lanca M, Lee-Lannotti J, Lefebvre R, Levy B, Lin J, Logarbo B, Logue J, Longo M, Luciano C, Lutrick K, Malakooti S, Mallett G, Maranga G, Marathe J, Marconi V, Marshall G, Martin C, Martin J, May H, McComsey G, McDonald D, Mendez-Figueroa H, Miele L, Mittleman M, Mohandas S, Mouchati C, Mullington J, Nadkarni G, Nahin E, Neuman R, Newman L, Nguyen A, Nikolich J, Ofotokun I, Ogbogu P, Palatnik A, Palomares K, Parimon T, Parry S, Parthasarathy S, Patterson T, Pearman A, Peluso M, Pemu P, Pettker C, Plunkett B, Pogreba-Brown K, Poppas A, Porterfield J, Quigley J, Quinn D, Raissy H, Rebello C, Reddy U, Reece R, Reeder H, Rischard F, Rosas J, Rosen C, Rouphael N, Rouse D, Ruff A, Saint Jean C, Sandoval G, Santana J, Schlater S, Sciurba F, Selvaggi C, Seshadri S, Sesso H, Shah D, Shemesh E, Sherif Z, Shinnick D, Simhan H, Singh U, Sowles A, Subbian V, Sun J, Suthar M, Teunis L, Thorp J, Ticotsky A, Tita A, Tragus R, Tuttle K, Urdaneta A, Utz P, VanWagoner T, Vasey A, Vernon S, Vidal C, Walker T, Ward H, Warren D, Weeks R, Weiner S, Weyer J, Wheeler J, Whiteheart S, Wiley Z, Williams N, Wisnivesky J, Wood J, Yee L, Young N, Zisis S, Foulkes A. Researching COVID to Enhance Recovery (RECOVER) adult study protocol: Rationale, objectives, and design. PLOS ONE 2023, 18: e0286297. PMID: 37352211, PMCID: PMC10289397, DOI: 10.1371/journal.pone.0286297.Peer-Reviewed Original ResearchConceptsSARS-CoV-2 infectionRisk factorsClinical risk factorsPost-acute sequelaePrimary study outcomeProportional hazards regressionCommunity-based outreachMulti-site observational studyPASC symptomsQuarterly questionnairesRetrospective cohortVaccination statusOrgan dysfunctionAcute phaseLong COVIDHazards regressionEligible participantsTreatment optionsPrior infectionStudy protocolClinical trialsNew symptomsLongitudinal cohortLaboratory examinationsObservational studyStudy protocol for a randomized, controlled trial using a novel, family-centered diet treatment to prevent NAFLD in Hispanic children
Welsh J, Pyo E, Huneault H, Ramirez L, Alazraki A, Alli R, Dunbar S, Khanna G, Knight-Scott J, Pimentel A, Reed B, Rodney-Somersall C, Santoro N, Umpierrez G, Vos M. Study protocol for a randomized, controlled trial using a novel, family-centered diet treatment to prevent NAFLD in Hispanic children. Contemporary Clinical Trials 2023, 129: 107170. PMID: 37019180, PMCID: PMC10734403, DOI: 10.1016/j.cct.2023.107170.Peer-Reviewed Original ResearchConceptsNon-alcoholic fatty liver diseaseHispanic childrenFuture dietary guidelinesFatty liver diseasePrimary study outcomeLiver fat accumulationHigh-risk childrenSignificant hepatic steatosisOne-year interventionPercentile BMIElevated liverSecondary outcomesNAFLD preventionLiver diseaseLiver steatosisNAFLD pathogenesisPrevious diagnosisHepatic fatHepatic steatosisStudy protocolDietary guidelinesFat accumulationLiver disordersMetabolic markersEligibility criteriaAccess to urologic cancer care for Medicaid-insured patients
Laditi F, Nie J, Hsiang W, Umer W, Haleem A, Marks V, Buck M, Leapman M. Access to urologic cancer care for Medicaid-insured patients. Urologic Oncology Seminars And Original Investigations 2023, 41: 206.e21-206.e27. PMID: 36740488, DOI: 10.1016/j.urolonc.2023.01.014.Peer-Reviewed Original ResearchConceptsUrologic cancer careCancer careMedicaid insuranceMedicaid acceptanceAcceptance of MedicaidPrimary study outcomeNew Medicaid patientsMedicaid expansion statusNon-expansion statesState Medicaid programsMedicare reimbursement ratesAffordable Care ActVulnerable patientsMedicaid patientsHospital statusKidney tumorsNew diagnosisPatientsHealthcare accessExpansion statusFacility characteristicsNon-teaching facilitiesStudy outcomesAmerican Hospital DirectoryMedicaid
2022
Long-term quantitative assessment of anti-SARS-CoV-2 spike protein immunogenicity (QUASI) after COVID-19 vaccination in older people living with HIV (PWH)
Tuan JJ, Zapata H, Barakat L, Andrews L, Behnegar A, Kim YW, Kayani J, Mutic S, Ryall L, Turcotte B, Critch-Gilfillan T, Zhao M, Salahuddin S, Gupta S, Sutton R, Friedland G, Emu B, Ogbuagu O. Long-term quantitative assessment of anti-SARS-CoV-2 spike protein immunogenicity (QUASI) after COVID-19 vaccination in older people living with HIV (PWH). BMC Infectious Diseases 2022, 22: 744. PMID: 36131232, PMCID: PMC9491266, DOI: 10.1186/s12879-022-07737-0.Peer-Reviewed Original ResearchConceptsT cell responsesAnti-spike IgGVisit 3SARS-CoV-2Older PWHVisit 2Immune responseSingle-center longitudinal observational studyVirus-specific T cell responsesVaccine-induced humoral immunityLong-term protective immunityT cell immune responsesOlder peopleMedian age 61RBD IgG levelsPrimary study outcomeCOVID-19 vaccinationImmune response evaluationLongitudinal observational studyCOVID-19 vaccineWilcoxon signed-rank testBNT162b2 boosterBNT162b2 vaccinationCD8 responsesDetectable CD4Hospital market concentration and the use of mechanical circulatory support devices in acute myocardial infarction complicated by cardiogenic shock
Vohra A, Jang S, Feldman D, Goyal P, Krishnan U, Sciria C, Cheung J, Kim L. Hospital market concentration and the use of mechanical circulatory support devices in acute myocardial infarction complicated by cardiogenic shock. BMC Health Services Research 2022, 22: 89. PMID: 35045849, PMCID: PMC8772168, DOI: 10.1186/s12913-021-07458-1.Peer-Reviewed Original ResearchConceptsUse of MCSMechanical circulatory supportAMI-CSAcute myocardial infarctionCardiogenic shockCirculatory supportMyocardial infarctionMechanical circulatory support devicesPrimary study exposurePrimary study outcomeMultivariable logistic regressionNational Inpatient SampleCirculatory support devicesHospital mortalityBaseline characteristicsInpatient SampleMore frequent useSubgroup analysisCompetitive hospital marketsMultivariable regressionQuery patientsStudy exposurePatientsLogistic regressionStudy outcomes
2021
Tenecteplase Reperfusion therapy in Acute ischaemic Cerebrovascular Events-II (TRACE II): rationale and design
Li S, Campbell B, Schwamm L, Fisher M, Parsons M, Li H, Pan Y, Wang Y. Tenecteplase Reperfusion therapy in Acute ischaemic Cerebrovascular Events-II (TRACE II): rationale and design. Stroke And Vascular Neurology 2021, 7: 71-76. PMID: 34446531, PMCID: PMC8899655, DOI: 10.1136/svn-2021-001074.Peer-Reviewed Original ResearchConceptsAcute ischemic strokeExcellent functional outcomeFunctional outcomeReperfusion therapyRt-PAAcute ischemic cerebrovascular eventsIntravenous thrombolysis therapyMajor neurological improvementSecondary efficacy outcomesHealth Stroke ScaleIschemic cerebrovascular eventsSymptomatic intracranial hemorrhageFavorable functional outcomeIschemic stroke onsetPrimary study outcomeRankin Scale 0Non-inferiority studyTissue-type plasminogen activatorCerebrovascular eventsNeurological improvementStroke ScaleEfficacy outcomesIschemic strokeStroke onsetThrombolysis therapy
2020
Association of Perceived Stress Levels With Long-term Mortality in Patients With Peripheral Artery Disease
Malik AO, Peri-Okonny P, Gosch K, Thomas M, Mena C, Hiatt WR, Jones PG, Provance JB, Labrosciano C, Jelani QU, Spertus JA, Smolderen KG. Association of Perceived Stress Levels With Long-term Mortality in Patients With Peripheral Artery Disease. JAMA Network Open 2020, 3: e208741. PMID: 32573710, PMCID: PMC7312389, DOI: 10.1001/jamanetworkopen.2020.8741.Peer-Reviewed Original ResearchConceptsModifiable risk factorsSelf-perceived stressChronic stressCause mortalityCohort studyRisk factorsCox proportional hazards regression modelLong-term mortality riskProportional hazards regression modelsSymptoms of PADLong-term mortalityPeripheral arterial diseasePeripheral artery diseasePrimary study outcomeEvidence-based management strategiesNational Death IndexHazards regression modelsRisk of mortalityAssessment of mortalityOnly patientsArtery diseaseFinal cohortArterial diseaseDeath IndexMulticenter study
2019
Fertility Related Quality of Life, Gonadal Function and Erectile Dysfunction in Male Partners of Couples with Unexplained Infertility.
Coward RM, Stetter C, Kunselman A, Trussell JC, Lindgren MC, Alvero RR, Casson P, Christman GM, Coutifaris C, Diamond MP, Hansen KR, Krawetz SA, Legro RS, Robinson RD, Smith JF, Steiner AZ, Wild RA, Zhang H, Santoro N. Fertility Related Quality of Life, Gonadal Function and Erectile Dysfunction in Male Partners of Couples with Unexplained Infertility. Journal Of Urology 2019, 202: 379-384. PMID: 30835629, PMCID: PMC6686175, DOI: 10.1097/ju.0000000000000205.Peer-Reviewed Original ResearchConceptsQuality of lifeLow total testosteroneTotal testosteroneErectile dysfunctionUnexplained infertilityFertiQoL scoresTestosterone levelsSemen parametersLow total testosterone levelsMultivariable logistic regression analysisMale partnersBaseline semen analysisWorse erectile dysfunctionTotal testosterone levelsAbnormal semen qualityPrimary study outcomePHQ-9 scoresBody mass indexMen of couplesLogistic regression analysisInfertility durationMen 59IIEF scorePatient ageSD age
2017
Association Between Targeted HER-2 Therapy and Breast Reconstruction Outcomes: A Propensity Score-Matched Analysis
Shammas R, Cho E, Glener A, Poveromo L, Mundy L, Greenup R, Blackwell K, Hollenbeck S. Association Between Targeted HER-2 Therapy and Breast Reconstruction Outcomes: A Propensity Score-Matched Analysis. Journal Of The American College Of Surgeons 2017, 225: 731-739.e1. PMID: 28985927, DOI: 10.1016/j.jamcollsurg.2017.08.023.Peer-Reviewed Original ResearchConceptsPostoperative wound breakdownBreast reconstructionReconstructive complicationsWound breakdownReconstructive operationsPropensity score-matched pairsMastectomy skin flap necrosisDuke University Medical CenterAdministration of trastuzumabPrimary study outcomeSkin flap necrosisLarger tumor sizePost-mastectomy reconstructionBreast reconstruction outcomesOccurrence of hematomaUniversity Medical CenterPertuzumab therapyChemotherapy regimenNeoadjuvant chemotherapyOperative interventionFlap thrombosisTrastuzumab therapySurgical outcomesTumor sizeFlap necrosis
2015
A Randomized Trial of Intrapartum Fetal ECG ST-Segment Analysis
Belfort M, Saade G, Thom E, Blackwell S, Reddy U, Thorp J, Tita A, Miller R, Peaceman A, McKenna D, Chien E, Rouse D, Gibbs R, El-Sayed Y, Sorokin Y, Caritis S, VanDorsten J. A Randomized Trial of Intrapartum Fetal ECG ST-Segment Analysis. Obstetrical & Gynecological Survey 2015, 70: 735-737. DOI: 10.1097/ogx.0000000000000276.Peer-Reviewed Original ResearchST-segment analysisFetal ECG ST segment analysisElectronic fetal monitoringApgar scoreCesarean deliveryNeonatal encephalopathyOperative deliveryPrimary outcomeVaginal deliveryRandomized trialsOpen groupElectronic fetal heart rate monitorMasked groupElectronic fetal heart rate monitoringFetal heart rate patternsUmbilical artery blood pHContinuous electronic fetal monitoringIntrapartum fetal deathFetal heart rate monitoringPrimary study outcomeOperative vaginal deliveryWeeks of gestationHeart rate patternsSignificant differencesFetal heart rate monitor
2014
Letrozole Versus Clomiphene for Infertility in the Polycystic Ovary Syndrome
Legro R, Brzyski R, Diamond M, Coutifaris C, Schlaff W, Casson P, Christman G, Huang H, Yan Q, Alvero R, Haisenleder D, Barnhart K, Bates G, Usadi R, Lucidi S, Baker V, Trussell J, Krawetz S, Snyder P, Ohl D, Santoro N, Eisenberg E, Zhang H. Letrozole Versus Clomiphene for Infertility in the Polycystic Ovary Syndrome. Obstetrical & Gynecological Survey 2014, 69: 599-601. DOI: 10.1097/01.ogx.0000456355.64379.77.Peer-Reviewed Original ResearchPolycystic ovary syndromeAdverse effect profileMultiple pregnancy rateEffect profileFertility agentsAromatase inhibitorsLive birthsHigher multiple pregnancy rateLower multiple pregnancy rateSelective estrogen receptor modulatorsMale partnersNormal uterine cavityPatent fallopian tubesPrimary study outcomeCumulative live birthReproductive-age womenGood safety profileEstrogen receptor modulatorsClomiphene groupLetrozole groupClomiphene citrateRotterdam criteriaHot flushesOvary syndromeInfertile womenThe Reliability of Teledermatology to Triage Inpatient Dermatology Consultations
Barbieri JS, Nelson CA, James WD, Margolis DJ, Littman-Quinn R, Kovarik CL, Rosenbach M. The Reliability of Teledermatology to Triage Inpatient Dermatology Consultations. JAMA Dermatology 2014, 150: 419-424. PMID: 24522374, DOI: 10.1001/jamadermatol.2013.9517.Peer-Reviewed Original Research
2013
Preventing Unintended Pregnancies by Providing No-Cost Contraception
Peipert J, Madden T, Allsworth J, Secura G. Preventing Unintended Pregnancies by Providing No-Cost Contraception. Obstetrical & Gynecological Survey 2013, 68: 289-291. DOI: 10.1097/01.ogx.0000429300.39964.d3.Peer-Reviewed Original ResearchReversible contraceptive methodsUnintended pregnancy ratesLARC methodsUnintended pregnancyContraceptive methodsTeenage birth ratesPregnancy rateRepeat abortionNational ratesAbortion rateProspective cohort studyPrimary study outcomePercentage of abortionsBirth rateContraceptive CHOICE ProjectCohort studyProvider referralContinuation ratesEligible participantsContraceptive counselingPostabortion contraceptionEffective contraceptionCost contraceptionPregnancyContraception
2012
Effectiveness of Long-Acting Reversible Contraception
Winner B, Peipert J, Zhao Q, Buckel C, Madden T, Allsworth J, Secura G. Effectiveness of Long-Acting Reversible Contraception. Obstetrical & Gynecological Survey 2012, 67: 552-553. DOI: 10.1097/01.ogx.0000421455.21771.a1.Peer-Reviewed Original ResearchUnintended pregnancyIntrauterine deviceContraceptive methodsContraceptive failureReversible contraceptionHazard ratioContraceptive pillsOlder womenLarge prospective cohort studyProspective cohort studyPrimary study outcomeOral contraceptive pillsCommon contraceptive methodsContraceptive failure ratesFinal multivariate modelLarge US populationReversible contraceptive methodsYears of ageLong-Acting Reversible ContraceptionFailure rateDMPA injectionCohort studyDaily dosingSecondary outcomesRate of failure
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply